Adipocyte differentiation is an ordered multistep process requiring the sequential activation of several groups of adipogenic transcription factors, including CCAAT/enhancer-binding protein-α and peroxisome proliferator-activated receptor-γ, and coactivators. In previous reports, we identified that replication factor C 140 (RFC140) protein played a critical role in regulating adipocyte differentiation as a coactivator. Here, we show expressional regulation of RFC140 and small RFC subunit, RFC38, following characterization of gene promoter of RFC140 and RFC38. In addition, RFC140 increases PPARγ -mediated gene activation, resulting from direct protein-protein interaction of RFC140 and PPARγ. Taken together, these findings demonstrate that the regulated expression of RFC140 and RFC38 by specific adipocyte transcription factors is required for the adipocyte differentiation process.
Introduction
The genetic program of adipogenesis has been studied extensively in vitro [6] with embryonic fibroblasts and preadipocyte lines, and in vivo [21, 26] with transgenic and knockout mouse models [9] , and a paradigm for the cascade of genetic events has emerged. After induction of differentiation, there is a rapid and transient induction of CCAAT/enhancer-binding protein beta (C/EBPβ) and C/EBPδ [4, 5] . These transcription factors then activate expression of both C/EBPα and peroxisome proliferator-activated receptor gamma (PPARγ), which then reinforce each other's expression through a positive feedback loop [20, 21] . PPARγ is a master transcriptional regulator for adipocyte differentiation and is important in regulation of a number of genes involved in fatty acid and glucose metabolism in adipocyte [8, 23] .
RFC is a five-subunit complex composed of 140-, 40-, 38-, 37-, and 36-kDa subunits [16] . Although RFC140 is primarily responsible for DNA binding, each of the subunits shares a conserved domain that is referred to as the PCNA interaction region [12] . In yeast, each individual subunit is an essential gene product that functions in the RFC complex to "load" PCNA onto DNA prior to genome duplication [15] . Together, DNA polymerase, PCNA, and RFC compose the replicative holoenzyme complex [7, 19] . But, it can be also suggested likely that RFC140 serves a role in regulating transcription in some manner, either directly by as a cofactor or through a DNA-modifying activity that allows transcription to proceed. The DNA-binding activity of the C/EBPα protein is regulated in the G1 phase of the hepatocyte cell cycle [11] . From these observations, it is suggested that RFC140 can affect the regulatory role of C/EBPα in the G1 phase necessary for cell differentiation such as hepatocyte and adipocyte. It is intriguing that C/EBPα, a transcription factor that was reported to induce cellular differentiation of adipocytes, hepatocytes and myelocytes, interacts with a component of the DNA replication apparatus.
Importantly, McGehee and Habener [17] showed that RFC140 was cloned as an important molecule for adipocyte differentiation and increases transcriptionally following the induction of differentiation. Additionally, the treatment of antisense oligonucleotides to RFC140 inhibited adipocyte differentiation [13] . Our earlier report showed that, in adipocyte differentiation, RFC140 expression is increased along with C/EBPα and RFC140 acts as a coactivator of C/EBPα for PPARγ gene expression [10] . The expression of PPARγ has been shown to be sufficient to induce growth arrest as well as to initiate adipogenesis in exponentially growing fibroblast cell lines, demonstrating its critical role in the regulation of adipocyte differentiation [1, 25] . Here we show that the expressional regulation of RFC140 and small RFC subunit, RFC38, following characterization of gene promoter of RFC140 and RFC38. In addition, RFC140 increases PPARγ -mediated gene activation, resulting from direct protein-pro-tein interaction of RFC140 and PPARγ.
Materials and Methods

Database search
Blast searches of GenBank were performed using the BLAST [2] service at the National Center for Biotechnology Information (NCBI, home page www.ncbi.nih.gov). For analyzing transcription factor binding sites in the promoter region, the TRANSFEC service was used.
Cloning of the human RFC140 promoter
The human RFC140 promoter was amplified by PCR twice on human normal spleen PCR Ready genomic DNA. For the primary PCR reaction, primers 5'-CATGGTGCT CCAAGAG-AGCAAGACAGGAGC-3' (F1) and 5'-ATCCA TTCGCGCCAA CAACTTCTCCCGCGA-3' (R1) were used. And for the secondary PCR reaction, primers 5'-CGACG CGTGCTGGCTG-CCAGTCTTCTTAAAGC-3' (F2) and 5'-ATACTCGAGGTGCAAGAAGGCGAGACAGT-3' (R2) were used. The PCR product was double digested with MluI and XhoI and cloned into the MluI-XhoI sites of the pGL3-Basic luciferase reporter plasmid (Promega).
Cloning of the human RFC38 promoter
The human RFC38 promoter was identified using Universal Genome Walker Kit according to the manufacturer's protocol (Clontech). The promoter was amplified by PCR twice. For the primary PCR reaction, RFC38 outer primer 5'-GCCGTCCCAAGGAGCAGGGCCGATAC-TTGT-3' and AP1 primer 5'-GTAATACGACTCACTATAGGGC-3' were used. And for the secondary PCR reaction, RFC38 nested primer 5'-CCACCCAGAGGCTCATGG-CAGCTCGAGT TC-3' and AP2 primer 5'-ACTATAGGGCACGCGTGGT-3' were used. PCR products were subcloned into pGEM-T Easy vector (Promega) and sequenced using the T7 forward and SP6 reverse primers. Sequencing was performed using the ABIPRISM automated DNA Sequencer model 310 (Applied Biosystem) at the sequencing facility of the Genotech.
Promoter DNA sequence was finally cloned at the SmaI sites of the pGL3-Basic luciferase reporter vector (Promega).
Cell culture and adipocyte differentiation 3T3-L1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (Gibco BRL) and 1% antibiotics.
To induce adipocyte differentiation, cells were grown until 2 days postconfluence (day 0) and then treated for 2 days with growth medium plus MDI (0.5 mM methylisobutylxanthine, 1 μM dexamethasone, and 10 μg/ml insulin, all from Sigma). The cells were re-fed with growth medium that contained 5 μg/ml insulin at day 2 and every 2 days thereafter with growth medium alone. HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% Fetal Bovine Serum (Gibco BRL), and 1% antibiotics.
Oil red O staining 3T3-L1 cells were washed twice with phosphate-buffered saline (PBS), fixed in 10% formalin, dissolved in PBS for 1 hr, and washed again once with PBS. Cells were then stained with 60% of a filtered oil red O stock solution (0.5 g of oil red O (Sigma) in 100 ml of 99% isopropanol) for 15 min. Cells were washed twice with water for 15 min each time and visualized.
Transient transfection assay
Transient transfections were done in 24-well plates with the standard calcium phosphate method. Cells were incubated with DNA precipitates for 16 hr, washed, and cell extracts were prepared 48 hr after transfection and assayed for relative luciferase and β-galactosidase activities. Basal promoter activity is reported as the activity observed after transfection of the reporter plus an appropriate amount of empty expression vector. In all cases, transfection data represent the mean of three independent experiments.
Mammalian two-hybrid assay Cells were seeded with growth medium supplemented with 10% fetal bovine serum and 1% antibiotics and cotransfected with expression vectors encoding Gal4-DNAbinding domain fusions (pCMX/Gal4N-, pCMX/Gal4N-RFC140 5'～151, pCMX/Gal4N-RFC140 151～545, pCMX/Gal4N-RFC140 151～3') and VP16-activation domain fusions (pCMX/VP16-, pCMX/VP16-PPARγ), along with the Gal4-tk-luc reporter plasmid. After 48 h, cells were harvested and the luciferase activity was normalized to the β -galactosidase internal standard. In all cases, transfection data represent the mean of three independent experiments.
Co-immunoprecipitation and Western blot RFC140 and PPAR were immunoprecipitated from 500 μg of total cell lysates of differentiation-induced 3T3-L1 cells. The protein content of cell lysates was determined with Bradford reagent (Bio-Rad) using bovine serum albumin (BSA) as standard.
After incubating with 0.5 μg of anti-RFC140 IgG (abcam) and 0.6 μg of anti-PPARγ IgG (Santa Cruz Biotechnology) in a total volume of 100 μl of ice-cold lysis buffer (50 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 10% Glycerol, 1 mM PMSF, 1 mM DTT, 20 mM NaF, 1 mM EDTA and protease inhibitor) for 2 hr at 4°C, 20 μl of protein G-Sepharose beads and protein A-Sepharose beads (1:1 slurry; Gibco BRL) were added and washed four times with lysis buffer. The precipitates were boiled with an equal volume of 2× Laemmli sample buffer (LSB) at 95°C for 3 min, separated on a 8% SDS-polyacrylamide gel and transfered to PVDF (Immobilon-P) membrane (Millipore). Coprecipitated RFC140 and PPARγ were detected by western blotting with anti-PPARγ IgG and anti-RFC140 IgG in TBS-T (TBS containing 0.04% Tween20) containing 2% skim milk for 1 hr at room temperature. After washing three times with TBS-T, secondary detection was carried out with horseradish peroxidase-conjugated anti-rabbit IgG and anti-goat IgG for 30 min at room temperature. After washing three times with TBS-T, the proteins were visualized by the enhanced chemiluminescent development reagent (Amersham Pharmacia Biotech).
RNA extraction and RT-PCR
The total mRNA of 3T3-L1 cells was extracted using the TRIzol Reagent (Invitrogen). The quantity and purity of the RNA prepared from each sample was determined by the ratio of the optical density at 260 nm to that at 280 nm. Gene expressions were determined by RT-PCR, using a RNA PCR kit incorporating avian myeloblastosis virus-derived RT and Taq DNA polymerase according to the manufacturer's protocol (TaKaRa Biomedicals). The RT reaction mixture was incubated at 42°C for 30 min, heated to 99°C for 10 min and then cooled to 4°C. The PCR mixture contained 2 μl of cDNA, 2.5 mmol/l MgCl2, 1× RNA PCR buffer, 0.2 μ mol/l RFC38 primers or β-actin primers and 2.5 U/100 μl Taq DNA polymerase in a total volume of 80 μl for each reaction. The PCR primers for RFC38 gene amplification were: 5' -GCCGTCCCAAGGAGCAGGGCCGATACTTGT-3'(F), 5'-CCACCCAGAGGCTCA-TGGCAGCTCGAGTTC-3'(R) and for β-actin gene amplification were : 5'-TCATGAAG-TGTGACGTTGACATCCGT-3'(F'), 5'-CTTAGAAGCATTTG CGGTGCACGATG-3'(R'). The PCR conditions for RFC38 gene amplification were: 32 cycles of denaturation at 94°C for 30 sec, annealing at 58°C for 1 min and extension at 72°C for 1 min in a thermal cycler. Triton X-100, 1.5 mM magnesium chloride, 10 mM sodium pyrophosphate, 10 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 200 mM sodium orthovanadate). Clarified cell lysates (1 mg of proteins) were incubated with anti-RFC140 antibody for 2 hr and protein A-Sepharose beads for 16 hr at 4°C. Immunoprecipitated proteins were washed three times with lysis buffer and the final bead pellets were resuspended in LSB, boiled, centrifuged, and resolved by SDS-PAGE and autoradiography.
Results
Characterization of the human RFC140 promoter In previous report, mRNA level of RFC 140 was increased during adipocyte differentiation [17] . However, it is unknown that how RFC140 expression is regulated. To understand the mechanism of RFC140 gene expression, the promoter region of RFC140 gene was identified. By searching genome databases, the DNA sequence of the RFC140 was and determined and submitted to the GenBank database with accession number AY600371. The human RFC140 promoter was obtained from human spleen genomic DNA by using PCR. A DNA fragment containing 1.6 kb of 5'-flanking sequence was cut with MluI and XhoI and cloned into the MluI-XhoI sites of the pGL3-Basic luciferase reporter plasmid. This reporter plasmid was used for transient transfection experiments in the human cancer cell line, HeLa cells.
The activation of the 1.6 kb promoter construct was confirmed in the luciferease reporter analysis (Fig. 1A) increased in dose-dependent manner of the transfected promoter amount (data not shown). Sequence analysis of the promoter region revealed that the first 300 bp of the putative RFC140 promoter is very GC-rich, a feature common for promoter regions and several consensus transcription factor binding sites are located in the promoter region but it contains no TATA or CCAAT boxes. A schematic presentation of the RFC140 promoter with binding sites for transcription factors is shown in Fig. 1B . The human RFC140 promoter containing 1.6 kb of 5'-flanking sequence was generated from human normal spleen genomic DNA and transfected in HeLa cells. The 620bp size construct was generated from 1.6kb RFC140 promoter as template. The smallest fragment generated using the indicated restriction sites (K-KpnI, X-XhoI) was linked to a pGL3-Basic luciferase reporter. These construct were transfected into the HeLa cells.
Effects of differentiation related transcription factors on hRFC140 promoter activation Several classes of transcription factors which are related to differentiation can regulate the expression of human RFC140 gene in time dependent manner. CREB and C/EBPβ play an important role in early stage of adipogenesis, and then C/EBPα and PPARγ play a role in middle and late one of adipogenesis [14] . To access which kinds of transcription factors affect the expression of RFC140 gene, transient transfection assay was performed. HeLa cells were transfected with the expression vectors encoding CREB, C/EBPβ, PPARγ, and C/EBPα, along with 1.6 kb RFC140 promoter. The transfection of CREB and C/EBPβ, which are expressed in early stage of adipogenesis, increased the promoter activity of RFC140 by 3-and 2.5-fold, respectively ( Fig.  2A, B) . In contrast to these, PPARγ, which is expressed in middle stage, did not contribute the increased activation of RFC140 promoter (Fig. 2C) . Although C/EBPα has similar transcriptional binding sites of C/EBPβ, it did not increase the promoter activity of RFC140 (Fig. 3D) . For the control experiment, C/EBPα increased the promoter activity of PPARγ (Fig. 2E) . These results suggest that only CREB and C/EBPβ increase the promoter activity of RFC140 during adipocyte differentiation. Based on the previous study that RFC140 interacts with C/EBPα during adipocyte differentiation [10] , the expression of RFC140 might be increased by CREB and C/EBPβ in early stage of adipogenesis, resulting in the enhanced RFC140 interaction with C/EBPα.
Identification of human RFC38 promoter
To further investigate which kinds of transcription factors affect the expression of RFC 38 until mitotic clonal expansion (MCE), the human RFC38 promoter was cloned by using Universal Genome Walker Kit according to the manufacturer's protocol (Clontech). The primary PCR amplification used the outer adaptor primer 5'-GTAATACGACTCACT ATAGGGC-3' and an outer gene specific primer 5'-GC CGTCCCAAGGAGCAGGGCCGATACTGT-3'. The primary PCR mixture was then diluted and used as a template for a secondary PCR amplification using the nested adaptor primer 5'-ACTATAGGGCACGCGTGGT-3' and a nested gene specific primer 5'-CCACCCAGAGGCTCATGGCAGCTCG AGTTC-3'. Fig. 3A shows results of primary and secondary Genome Walker PCR. Amplification of each of the Human Genome Walker libraries with the adaptor primers and primers derived from exon 1 of the RFC38 gene gen- PvuII library and 0.6 kb product with SspI library of the size expected based on the map. Three PCR products except 0.25 kb product were subcloned into pGEM-T Easy vector (Promega) and sequenced using the T7 forward and SP6 reverse primers. Sequencing was performed using the ABIPRISM automated DNA Sequencer model 310 (Applied Biosystem) at the sequencing facility of the Genotech. A DNA fragment containing 0.6 kb 5'-flanking sequence was finally cloned at the SmaI sites of the pGL3 Basic luciferase reporter plasmid (Promega). To test the activity of the promoter, it was transfected in HeLa cells. The activity of the 0.6 kb RFC38 promoter was increased in dose-dependent manner of the transfected promoter amount (data not shown). The nucleotide upstream of the transcription start site was numbered from -1 and several consensus transcription factor binding sites are located in the promoter region (Fig. 3B ).
Differential expression of RFC38 with RFC140 during adipocyte differentiation After induction of differentiation, postconfluent and growth-arrested 3T3-L1 preadipocytes synchronously reenter the cell cycle and undergo several rounds of MCE at very early stage of differentiation. Recent evidence has established that MCE is required for the progression of the differentiation program [24] . Also, for DNA replication, RFC140 is required to form an active complex with other four small subunits [16] . To access whether RFC140 has a regulatory role of adipogenesis dependent on complex formation or not, the expression pattern of other subunit of RFC was examined by RT-PCR. Because it is known that RFC38 and RFC40 bind RFC140, mRNA levels of these subunits were investigated. Total mRNA was isolated from 3T3-L1 cells on the indicated time after induction of differentiation. In contrast to RFC140, the mRNA levels of RFC38 and RFC40 were maintained to early stage but significantly decreased from 2 days during adipocyte differentiation (Fig. 4A) . These results suggest that RFC140 functions as complex until MCE and as a monomer after middle stage of adipogenesis.
Effects of differentiation related transcription factor on hRFC38 promoter activation In order to access which kinds of transcription factors affect the expression of RFC38 promoter, transient transfection assay was performed. HeLa cells were transfected with the expression vectors encoding C/EBPβ, and ATF2. As a result, C/EBPβ and ATF2 which are expressed in early stage of adipogenesis increased the promoter activity of RFC38 by 2.2-fold and 2.3-fold, respectively. These results indicate that C/EBPβ can increase the promoter activity of RFC38 as well as RFC140 earlier in the differentiation program, i.e., during MCE.
The interaction of RFC140 and PPAR in adipocyte differentiation
The protein level of RFC140 was increased after induction of adipocyte lineage differentiation of 3T3-L1 cells by inducers [17] . The transcription factor PPARγ is known to be both necessary and sufficient for adipocyte differentiation. These results suggest the possibility that PPARγ has functional interaction with RFC140 in the adipocyte differentiation procedure. To examine whether the protein interaction between RFC140 and PPARγ would be found in the differentiation process of adipocytes, transient transfection assay was performed. HeLa cells were transfected with the indicated amounts of expression vectors encoding RFC140 and PPARγ, along with the PPRE promoter linked to the luciferase gene. 48 hr after transfection, cells were harvested for luciferase assay. Whereas the transfection of RFC140 alone did not significantly affect basal reporter activity, the transfection of PPARγ alone stimulated the promoter activity of PPRE by 18-fold. When cells were cotransfected with PPARγ and RFC140, the promoter activity of PPRE was increased by 25-and 40-fold in RFC140 dose dependent manner (Fig. 5A) . To confirm the interaction of two factors, co-immunoprecipitation was performed. As shown in Fig. 5B, RFC140 was detected in the co-immunoprecipitated protein fractions by anti-PPARγantibody using differentiation-induced cell lysates at the 3rd and 5th days after inducer treatment. Reversely, PPARγ was detected in the co-immunoprecipitated protein fractions by anti-RFC140 antibody using differentiation-induced cell lysates at the 3rd and 5th days after inducer treatment. This interaction was not found in undifferentiated cell lysates and in +  +  +  --+  ---------+  --------+  ---------+  ------------+  --+  +  +  ----+  --+  +  +  ---+  ----+  ----+  ----+ - the first day lysates after differentiation induction. Lastly, to address the binding domain of RFC140 with PPARγ, mammalian two-hybrid assay was performed. As shown in Fig. 5C , coexpression of Gal4-RFC140 NH2-terminal region and VP16-PPARγ enhanced Gal4-tk-luc-dependent transactivation, but coexpression of Gal4-RFC140 COOH-terminal region and VP16-PPARγ didn't affect the activity of Gal4-tk-luc. These results indicate that RFC140 can interact with PPARγ through the NH2-terminal region and function as co-activator.
Discussion
Adipocyte differentiation is a complex process accompanied by coordinated changes in morphology, hormone sensitivity, and gene expression. These changes are regulated by several transcription factors such as C/EBPs, PPAR γ, and ADD1/SREBP1c [22] . These transcription factors are induced at different stages of adipocyte differentiation and functionally interact with each other to conduct adipogenesis and lipogenesis by regulating gene expression [3] . RFC is a five-subunit complex composed of 140-, 40-, 38-, 37-and 36-kDa subunits [18] . Although RFC140 is primarily responsible for DNA replication and repair, it has been demonstrated that RFC140 is important to regulate gene expression.
In the previous paper, it was demonstrated that mRNA level of RFC 140 has increased during adipocyte differentiation. However, the molecular mechanism of RFC140 gene expression during adipocyte differentiation is largely unknown.
In this study, to investigate the mechanism of RFC140 gene expression, the promoter region of RFC140 gene was identified. Through the transient transfection assay, it was demonstrated that CREB and C/EBPβ bind to the promoter of RFC140 gene in early stage of adipocyte differentiation and activate the expression of RFC140 gene in dose-dependent manner ( Fig. 2A and B) , but PPARγ and C/EBPα expressed in middle and late stage of adipocyte differentiation do not increase the promoter activity ( Fig. 2C and D) . To access whether RFC140 functions as complex or monomer during adipogenesis, mRNA levels of RFC38 and RFC40 were investigated and elucidated that they are maintained until MCE but significantly decreased during adipocyte terminal differentiation (Fig. 4A) . Also, it was demonstrated that C/EBPβ and ATF2 bind to the promoter region of RFC38 gene in early stage of adipocyte differentiation and activate the expression of RFC38 in dose-dependent manner during mitotic clonal expansion stage. However, to know the regulatory mechanism of RFC140 by CREB and C/EBPβ in detail, Chromatin Immunoprecipitation (ChIP) should be performed with antibodies directed against transcription factors after identifying of DNA regions which are bound by CREB and C/EBPβ.
In previous report, when the differentiation inducer, insulin was treated in 3T3-L1 cells, RFC140 was phosphorylated by activated CaMKII and the phosphorylated RFC140 largely increased the coactivator activity of RFC140 on C/EBPα-mediated transactivation. Thus, it will be interesting to examine how the coactivator activity of RFC140 can be increased by phosphorylation. As several possibilities, RFC140 can increase the DNA binding activity of C/EBPα or recruit other coactivators to the region well. Another possibility is that it may serve a role in regulating transcription through a DNA modifying activity that allows transcription to proceed, because it has a helicase like domain.
The function of PPARγ is especially critical, since many of the genes involved in adipogenesis, as well as glucose homeostasis, are activated by this nuclear hormone receptor. On the previous data, it was shown that RFC140 interacts with C/EBPα during adipogenesis. So, it was assumed that RFC140 might be able to interact with other factors related adipocyte differenciation. By co-immunoprecipitation analysis, it was demonstrated that the general DNA replication factor RFC140 physically interact with an important transcription factor PPARγ. Through the interaction RFC140 with PPARγ as well as C/EBPα, it was considered that RFC140 is a major factor in adipocyte differentiation not by interacting a specific "only one" factor but by associating many factors related adipocyte differentiation. In short, it seems that RFC140 functions broadly. For the further study, it is necessary to investigate the interaction with other factors-SREBP and LXR, because they are associated in adipocyte differentiation. Lastly, to address the binding domain of RFC140 with PPARγ, mammalian two-hybrid assay was performed and showed the possibility that RFC140 interacts with PPARγ through the NH2-terminal domain.
In summary, the interpretation of results in the context of the cascade model of adipocyte differentiation can be supposed to explain the functional regulation of RFC140. First, the expression of RFC140 is regulated by CREB and C/EBPβ and that of RFC38 is increased by C/EBPβ and ATF2 in early stage of adipogenesis. RFC140 functions as complex until MCE and as a monomer after middle stage of adipogenesis. Second, RFC140 is phosphorylated by activated CaMKII and the phosphorylated RFC140 largely increases the coactivator activity of RFC140 on C/EBPα -mediated transactivation. Third, RFC140 plays an important role by interacting with PPARγ, which is a key regulator of adipocyte differentiation. RFC140 may enhance the function of target gene enhancesome by juxtaposing components of the transcriptional machinery in a more favorable orientation, and may also play a role in recruiting transcriptional coactivators.
